PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-37.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-32.44%
Negative gross profit growth while 8198.HK is at 652.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
39.12%
Operating income growth above 1.5x 8198.HK's 18.98%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
9.82%
Net income growth under 50% of 8198.HK's 26.34%. Michael Burry would suspect the firm is falling well behind a key competitor.
8.00%
EPS growth under 50% of 8198.HK's 26.22%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
8.00%
Diluted EPS growth under 50% of 8198.HK's 26.48%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.70%
Share count expansion well above 8198.HK's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.70%
Diluted share count expanding well above 8198.HK's 0.40%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
99.28%
OCF growth of 99.28% while 8198.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
99.97%
FCF growth of 99.97% while 8198.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-11.98%
Negative 10Y revenue/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-68.68%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-55.35%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
2680.63%
OCF/share CAGR of 2680.63% while 8198.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
405.48%
Positive OCF/share growth while 8198.HK is negative. John Neff might see a comparative advantage in operational cash viability.
49.13%
Positive 3Y OCF/share CAGR while 8198.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-49.61%
Negative 10Y net income/share CAGR while 8198.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-59.07%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
552.73%
3Y net income/share CAGR above 1.5x 8198.HK's 18.23%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
1.59%
Below 50% of 8198.HK's 273.84%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.84%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 8198.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-42.29%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-58.41%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-8.31%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.18%
BV/share growth of 0.18% while 8198.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-78.21%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.73%
We cut SG&A while 8198.HK invests at 120.19%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.